Valneva SE (VALN) Payables (2020 - 2026)
Valneva SE's (VALN) quarterly Payables came in at $25.5 million in Q1 2026, down 12.81% year-on-year from $29.3 million in Q1 2025, and down 10.63% quarter-over-quarter from $28.6 million in Q4 2025.
Valneva SE (VALN) Payables (2020 - 2026) Analysis & Trends
Valneva SE has disclosed Payables across 7 years of filings, most recently posting $25.5 million for Q1 2026.
- Payables for Q1 2026 came in at $25.5 million, down 12.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.5 million (down 12.81% YoY), and the FY2025 annual result was $28.6 million, down 24.75% from the prior year.
- Payables came in at $25.5 million for Q1 2026 at Valneva SE, down from $28.6 million in the prior quarter.
- In the past five years, Payables ranged from a high of $102.6 million in Q3 2023 to a low of $23.9 million in Q2 2025.
- The 5-year median for Payables is $38.0 million (2024), against an average of $49.5 million.
- Across the five-year window, Payables surged 35.71% in 2023 and plunged 54.08% in 2024, its largest moves.
- Valneva SE's Payables stood at $42.3 million in 2022, then increased by 12.61% to $47.7 million in 2023, then dropped by 20.37% to $38.0 million in 2024, then retreated by 24.75% to $28.6 million in 2025, then dropped by 10.63% to $25.5 million in 2026.
- The last three Payables figures came in at $25.5 million (Q1 2026), $28.6 million (Q4 2025), and $35.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 34.55 Mn |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | 25.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.53 Mn |
| Dec 31, 2025 | 28.57 Mn |
| Sep 30, 2025 | 35.21 Mn |
| Jun 30, 2025 | 23.90 Mn |
| Mar 31, 2025 | 29.28 Mn |
| Dec 31, 2024 | 37.96 Mn |
| Sep 30, 2024 | 47.11 Mn |
| Jun 30, 2024 | 35.16 Mn |
| Mar 31, 2024 | 36.40 Mn |
| Dec 31, 2023 | 47.67 Mn |
| Sep 30, 2023 | 102.59 Mn |
| Jun 30, 2023 | 75.30 Mn |
| Mar 31, 2023 | 35.98 Mn |
| Dec 31, 2022 | 42.33 Mn |
| Sep 30, 2022 | 75.59 Mn |
| Jun 30, 2022 | 89.32 Mn |
| Mar 31, 2022 | 74.38 Mn |
| Dec 31, 2021 | 86.06 Mn |
| Dec 31, 2020 | 51.51 Mn |